PD-L1 Expression and Survival among Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy
about
The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial Carcinoma.Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy.Immune checkpoints and their inhibition in cancer and infectious diseases.Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.Lung Cancer Biomarkers.A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes.PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis.Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.Prognostic significance of PD-L1 expression and tumor infiltrating lymphocyte in surgically resectable non-small cell lung cancer.Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma.Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.Importance of immune monitoring approaches and the use of immune checkpoints for the treatment of diffuse intrinsic pontine glioma: From bench to clinic and vice versa (Review).In-office tooth bleaching with 38% hydrogen peroxide promotes moderate/severe pulp inflammation and production of ll-1β, TNF-β, GPX, FGF-2 and osteocalcin in rats.
P2860
Q37530339-78DD102B-8088-4738-A81C-31FC8D7A0882Q37656305-919BC84E-07AE-4DE5-BE68-6FCFAE4BBA9CQ38845026-4C27AB08-EDDD-4CC1-A530-3F9B1688331DQ38902971-D6796E39-F46B-490D-9B59-69B1A930048FQ39027394-951CEFB2-F736-4030-8482-5E950755394EQ41306256-75C9646C-B2DC-4865-A615-E772B13D630DQ41579669-106BB06C-412A-4EFC-82D0-2338AFCC45BFQ42314661-07934890-0892-496F-91AD-68395E7E0DE0Q46642782-37467C2E-FED2-4676-BDC4-A285A448AEBEQ47099687-C0DF130B-26E7-4163-B3AF-4E6352264322Q50300234-8D1F976F-1788-45D9-BFC9-731A9FB365E6Q52683991-F9476924-C1C5-4C39-9714-35286223099DQ55260614-6668F56B-06A9-497A-8CFC-ABF4C221289B
P2860
PD-L1 Expression and Survival among Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
PD-L1 Expression and Survival ...... ncer Treated with Chemotherapy
@ast
PD-L1 Expression and Survival ...... ncer Treated with Chemotherapy
@en
type
label
PD-L1 Expression and Survival ...... ncer Treated with Chemotherapy
@ast
PD-L1 Expression and Survival ...... ncer Treated with Chemotherapy
@en
prefLabel
PD-L1 Expression and Survival ...... ncer Treated with Chemotherapy
@ast
PD-L1 Expression and Survival ...... ncer Treated with Chemotherapy
@en
P2093
P2860
P1476
PD-L1 Expression and Survival ...... ncer Treated with Chemotherapy
@en
P2093
Henrik Hager
Jeanette Baehr Georgsen
Kenneth Emancipator
Marisa Dolled-Filhart
Steffen Filskov Sorensen
P2860
P356
10.1016/J.TRANON.2016.01.003
P577
2016-02-01T00:00:00Z